- Home
- TSHA vs PSFE Comparison
TSHA vs PSFE Comparison
Compare TSHA & PSFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- PSFE
- Stock Information
- Founded
- TSHA 2019
- PSFE 1996
- Country
- TSHA United States
- PSFE United Kingdom
- Employees
- TSHA N/A
- PSFE N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- PSFE Business Services
- Sector
- TSHA Health Care
- PSFE Consumer Discretionary
- Exchange
- TSHA Nasdaq
- PSFE Nasdaq
- Market Cap
- TSHA 728.4M
- PSFE 770.1M
- IPO Year
- TSHA 2020
- PSFE N/A
- Fundamental
- Price
- TSHA $3.02
- PSFE $13.96
- Analyst Decision
- TSHA Strong Buy
- PSFE Sell
- Analyst Count
- TSHA 7
- PSFE 4
- Target Price
- TSHA $8.71
- PSFE $17.38
- AVG Volume (30 Days)
- TSHA 3.5M
- PSFE 263.3K
- Earning Date
- TSHA 11-12-2025
- PSFE 11-12-2025
- Dividend Yield
- TSHA N/A
- PSFE N/A
- EPS Growth
- TSHA N/A
- PSFE N/A
- EPS
- TSHA N/A
- PSFE N/A
- Revenue
- TSHA $8,098,000.00
- PSFE $1,676,391,000.00
- Revenue This Year
- TSHA N/A
- PSFE $3.18
- Revenue Next Year
- TSHA N/A
- PSFE $7.05
- P/E Ratio
- TSHA N/A
- PSFE N/A
- Revenue Growth
- TSHA N/A
- PSFE 0.47
- 52 Week Low
- TSHA $1.05
- PSFE $10.63
- 52 Week High
- TSHA $3.40
- PSFE $26.25
- Technical
- Relative Strength Index (RSI)
- TSHA 51.14
- PSFE 52.59
- Support Level
- TSHA $3.16
- PSFE $13.86
- Resistance Level
- TSHA $2.99
- PSFE $14.45
- Average True Range (ATR)
- TSHA 0.18
- PSFE 0.48
- MACD
- TSHA -0.01
- PSFE -0.02
- Stochastic Oscillator
- TSHA 38.21
- PSFE 44.24
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About PSFE Paysafe Limited
Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company provides payment solutions through three primary lines of business: Integrated Processing, Digital Wallet and eCash Solutions. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.